Efficacy Study of Inecalcitol With Decitabine in Acute Myeloid Leukemia Patients Unfit for Standard Chemotherapy

Clinical trial NCT02802267 · UNKNOWN

Trial details

NCT number: NCT02802267
Sponsor: Hybrigenics Corporation
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myelogenous Leukemia

Start date: 2016-06-01
Primary completion: 2018-12-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.